Samsung Biologics to buy Polypeptide Group shares for 2.7 trln won
Samsung Biologics and Samsung Peptide will buy shares in Polypeptide Group AG worth 2.7 trln won.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.